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Abstract
A 36-year-old parturient with a suspicion of placenta accreta under tocolytic therapy with ritodrine infusion
underwent emergency cesarean section under general anesthesia with propofol, ketamine, and remifentanil
because massive bleeding was anticipated. The ritodrine infusion was discontinued 1 h before cesarean section.
The baby was delivered 6 min after induction of anesthesia. However, after the manual removal of the placenta
from the uterus, the bleeding was massive and uncontrollable. We rapidly transfused crystalloid, colloid, and red
blood cells through potassium removal filter. Hyperkalemia (5.8 mmol/L) was detected just before blood
transfusion. One hour later, hemostasis was still difficult, and hyperkalemia was promoted (6.1 mmol/L). Thus,
glucose insulin therapy started with intravenous furosemide to treat hyperkalemia. Gynecologists decided to
induce the Bakri balloon tamponade for the treatment of postpartum hemorrhage. At the end of surgery, plasma
potassium level also reduced to 5.5 mmol/L. In the ICU, the bleeding still continued, and then radiologists
performed bilateral internal iliac artery embolization for full hemostasis. Postoperative plasma potassium level
was stable and 3.3 mmol/L in the next morning. Although one of the common adverse reactions of ritodrine is
hypokalemia, we should also beware of a rebound hyperkalemia after its cessation.
Keyword: Ritodrine, Cesarean section, Hyperkalemia
Background
Ritodrine, a β2-adrenergic agonist, is widely used for
tocolytic therapy in parturients. However, one of the
common adverse effects of β2-agonists is hypokalemia
(relative risk, 6.07; 95% confidence interval, 4.00 to 9.20)
[1], which is due to an increase in uptake of extracellular
potassium by promoting insulin secretion in pancreatic
islets with β2 adrenoceptor stimulation [2]. However, we
experienced a case revealing a rebound hyperkalemia
after cessation of ritodrine. This adverse reaction may
rarely occur as only five case reports have been found by
PubMed search [3–7].
Case presentation
We have obtained a written informed consent for publi-
cation of this case report from the patient.
A 36-year-old parturient (170 cm, 74.8 kg, gravida 1,
para 1) with a suspicion of placenta accreta at 34 weeks
gestation was admitted into our university hospital. She
did not have any abnormal medical history. On the 3rd
day after admission, tocolytic therapy against frequent
uterine contractions started with intravenous infusion of
ritodrine at 50 μg/min. On the 5th day, its infusion dose
reduced to 35 μg/min because of her palpitation with
tachycardia (HR 120 bpm). On the 6th day, the serum
potassium level was 4.1 mmol/L. On the 7th day, as
spontaneous amniorrhexis occurred, emergency cesarean
section was scheduled, and the ritodrine infusion was
discontinued (1 h before cesarean section).
We chose general anesthesia for the emergency
cesarean section as massive bleeding due to placenta
accreta was anticipated. Anesthesia was induced with
intravenous propofol (150 mg) and suxamethonium
(50 mg) followed by tracheal intubation uncompli-
catedly, and then maintained with propofol (6 mg/kg/h)
till delivery. The baby was delivered 6 min after
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induction of anesthesia. Then, fentanyl and ketamine
were additionally given to deepen anesthesia. Rocuro-
nium was also given to maintain muscle relaxation. After
the manual removal of the placenta from the uterus, the
bleeding was massive and uncontrollable (2200 g in
about 20 min). We rapidly transfused colloidal solution
against hypotension (63/35 mmHg), and blood pressure
increased to 90/50 mmHg within 10 min. We also estab-
lished an arterial line to left radial artery to maintain
blood pressure. Arterial blood gas analyses revealed
hyperkalemia (5.8 mmol/L), anemia (Hb 5.0 g/dL), and
mild metabolic acidosis (pH 7.33, base excess (BE)
−4.5 mEq/L, lactate 1.7 mmol/L). We started blood
transfusion with potassium removal filter (potassium ad-
sorption filter (KPF-4), Kawasumi, Tokyo). One hour
later, hemostasis was still difficult, and the biochemical
date showed further hyperkalemia (6.1 mmol/L) without
any electrocardiographic changes and development of
metabolic acidosis (pH 7.33, BE –5.2 mEq/L, lactate
1.0 mmol/L). To treat hyperkalemia, glucose insulin
therapy started with intravenous furosemide (10 mg).
Because of insufficient hemostasis, gynecologists decided
to induce the Bakri balloon tamponade for the treatment
of postpartum hemorrhage. At the induction of the Bakri
balloon, the hematological data were improved (Hb
6.1 g/dL). In addition, plasma potassium level also re-
duced to 5.5 mmol/L. Thus, the operation was termi-
nated (1 h 54 min) with a total blood loss of 4000 g and
urine output of 400 mL. Crystalloid (800 mL), colloid
(HES 130/0.4) (1500 mL), 5% albumin (500 mL), and
packed red blood cell (6 units) were totally transfused
during operation. She postoperatively moved to the in-
tensive care unit under propofol sedation with tracheal
intubation. The trachea was extubated after confirming
stable hemodynamics and oxygenation. However, as the
bleeding still continued, radiologists finally performed
bilateral internal iliac artery embolization for full
hemostasis. The postoperative course was uneventful
and plasma potassium level was 3.3 mmol/L in the next
morning. She was discharged from the hospital on foot
without any sequelas on the 13th postoperative day.
Discussion
Ritodrine is a β2-mimetic and commonly used for man-
agement of preterm labor. The common side effect of
ritodrine is hypokalemia as β2-adrenoceptor stimulation
in pancreatic islets by ritodrine promotes insulin secre-
tion to increase uptake of extracellular potassium [2].
However, in the present case, hyperkalemia occurred 1 h
after cessation of ritodrine. Vanishing β2-stimulation fol-
lowing cessation of ritodrine conversely increases efflux
of potassium from the cells to increase plasma potas-
sium levels. Indeed, there are several similar case reports
revealing hyperkalemia following cessation of ritodrine
in parturients [3–7]. In addition, in the present case, sur-
gical stress with massive bleeding could reduce insulin
secretion and induce insulin resistance by increases in
catecholamine and cortisol release. As a result, efflux of
potassium from the cell was promoted to enhance
hyperkalemia.
In the present case, hyperkalemia became rapidly ap-
parent even 1 h after cessation of ritodrine infusion. It
has been reported that plasma ritodrine concentration
rapidly declines following termination of its infusion
with a distribution half-time of 5.9 ± 6.0 min and a dis-
position half-time of 156 ± 51 min [8]. Thus, we have to
monitor plasma potassium levels around 3 h after ces-
sation of ritodrine. Indeed, Kotani and colleagues [5]
reported that maximal hyperkalemia was observed 90–
150 min after its cessation in six patients.
Unexpected hyperkalemia following intravenous
suxamethonium has also been reported in parturients
treated with magnesium and ritodrine under prolonged
immobilization [6]. As suxamethonium was used to fa-
cilitate tracheal intubation in the present case, it might
reinforce ritodrine-induced rebound hyperkalemia. Al-
though plasma potassium levels may increase up to
1.0 mmol/L within 2–5 min following intravenous
suxamethonium and the level quickly returns to a base-
line value in healthy persons [9], hyperkalemia was
detected even 1 h after iv suxamethonium. Therefore,
iv suxamethonium may not be the main cause of hyper-
kalemia in the present case.
The following causes of perioperative hyperkalemia
should also be considered: rhabdomyolysis from malpo-
sitioning, tissue ischemia, metabolic and respiratory
acidosis, and blood transfusion [9]. In the present case,
as positioning was carefully done to avoid peripheral
nerve injury, rhabdomyolysis could be excluded from
the cause. Although the lowest blood pressure was 63/
35 mmHg, blood pressure increased to 90/50 mmHg by
rapid blood and colloid transfusion. In addition, intraop-
erative plasma lactate level was also within normal
(<2 mmol/L) during surgery. Thus, tissue ischemia could
also be excluded. As arterial blood gas analysis revealed
mild metabolic acidosis (BE, –4.5 and –5.2 mEq/L), it
might cause an increase in plasma potassium level.
However, a parturient generally show low arterial CO2
with a parallel reduction in plasma HCO3
− because of
hyperventilation induced by effects of progesterone on
the respiratory center [10]. Particularly in labor, BE and
HCO3
− decrease to −4.8 and 20.3 mEq/L [10]. Therefore,
slight low BE in the present case would be acceptable
and would not cause hyperkalemia.
Conclusions
In summary, we experienced a case of rebound hyperka-
lemia after cessation of ritodrine in a parturient
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undergoing an emergency cesarean section with massive
bleeding. We should pay attention to perioperative
hyperkalemia in a parturient treated with ritodrine for
tocolytic therapy.
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